Top

Virology Journal

Published in:

Open Access 01-12-2010 | Research

Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma

Authors: Ajay Kumar Chaudhary, Shruti Pandya, Ravi Mehrotra, Alok C Bharti, Mangal Singh, Mamta Singh

Published in: Virology Journal | Issue 1/2010

Abstract

Background

Oral malignancy is a major global health problem. Besides the main risk factors of tobacco, smoking and alcohol, infection by human papillomavirus (HPV) and genetic alterations are likely to play an important role in these lesions. The purpose of this study was to compare the efficacy of HC-II assay and PCR for the detection of specific HPV type (HPV 16 E6) in OSMF and OSCC cases as well as find out the prevalence of the high risk HPV (HR-HPV) in these lesions.

Methods and materials

Four hundred and thirty patients of the potentially malignant and malignant oral lesions were taken from the Department of Otorhinolaryngology, Moti Lal Nehru Medical College, Allahabad, India from Sept 2007-March 2010. Of which 208 cases were oral submucous fibrosis (OSMF) and 222 cases were oral squamous cell carcinoma (OSCC). The HC-II assay and PCR were used for the detection of HR-HPV DNA.

Result

The overall prevalence of HR-HPV 16 E6 DNA positivity was nearly 26% by PCR and 27.4% by the HC-II assay in case of potentially malignant disorder of the oral lesions such as OSMF. However, in case of malignant oral lesions such as OSCC, 32.4% HPV 16 E6 positive by PCR and 31.4% by the HC-II assay. In case of OSMF, the two test gave concordant result for 42 positive samples and 154 negative samples, with an overall level of agreement of 85.4% (Cohen's kappa = 66.83%, 95% CI 0.553-0.783). The sensitivity and specificity of the test were 73.7% and 92.05% (p < 0.00). In case of OSCC, the two test gave concordant result for 61 positive samples and 152 negative samples, with an overall level of agreement of 88.3% (Cohen's kappa = 79.29, 95% CI 0.769-0.939) and the sensitivity and specificity of the test were 87.14% and 92.76% (p < 0.00).

Conclusion

This study concluded that slight difference was found between the positivity rate of HR-HPV infection detected by the HC-II and PCR assay in OSMF and OSCC cases and the HC II assay seemed to have better sensitivity in case of OSCC.

Available only for authorised users

Warnakulasuriya S, Johnson NW, van der Waal I: Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007,36(10):575-80. 10.1111/j.1600-0714.2007.00582.xPubMedCrossRef

Shah B, Lewis MA, Bedi R: Oral sub mucous fibrosis 11 year-old Bangladeshi girl living in United Kingdom. Br Dent J 2001,191(3):130-2. 10.1038/sj.bdj.4801117aPubMedCrossRef

Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ: Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 2002,11(7):646-53.PubMed

Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M: Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev 2008,9(2):263-5.PubMed

Chaudhary AK, Singh M, Sundaram S, Mehrotra R: Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol 2009, 1: 22. 10.1186/1758-3284-1-22PubMedPubMedCentralCrossRef

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000,92(9):709-20. 10.1093/jnci/92.9.709PubMedCrossRef

Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005,14(2):467-75. 10.1158/1055-9965.EPI-04-0551PubMedCrossRef

Gillison ML: Human papillomavirus associated head and neck cancer is a distinct epidemiologic, clinical and molecular entity. Semin Oncol 2004,31(6):744-54. 10.1053/j.seminoncol.2004.09.011PubMedCrossRef

Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoudis A, Tsoli E, Danassi-Afentaki D, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C: "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000,13(6):644-53. 10.1038/modpathol.3880113PubMedCrossRef

10.

Baker CC, Phelps WC, Lingren V, Braun MJ, Gonda MA, Howley PM: Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987,61(4):962-971.PubMedPubMedCentral

11.

Jeon S, Allen-Hoffmann BL, Lambert PF: Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantages of cells. J Virol 1995,69(5):2989-97.PubMedPubMedCentral

12.

Romanczuk H, Howley PM: Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci USA 1992,89(7):3159-63. 10.1073/pnas.89.7.3159PubMedPubMedCentralCrossRef

13.

Schwarz E, Freese UK, Gissmann L, Wolfgang M, Roggenbuck B, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985,314(6006):111-4. 10.1038/314111a0PubMedCrossRef

14.

Hudson JB, Bedell MA, McCance DJ, Laimins LA: Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 1990,64(2):519-26.PubMedPubMedCentral

15.

Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989,63(10):4417-21.PubMedPubMedCentral

16.

Schneede P, Hillemanns P, Ziller F, Hofstetter A, Stockfleth E, Arndt R, Meyer T: Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening. Acta Obstet Gynecol Scand 2001,80(8):750-2.PubMedCrossRef

17.

Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A: Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol 2001,65(1):155-62. 10.1002/jmv.2015PubMedCrossRef

18.

Venturoli S, Cricca M, Bonvicini F, Giosa F, Pulvirenti FR, Galli C, Musiani M, Zerbini M: Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J Clin Virol 2002,25(2):177-85. 10.1016/S1386-6532(02)00007-0PubMedCrossRef

19.

Tsiodras S, Georgoulakis J, Chranioti A, Voulgaris Z, Psyrri A, Tsivilika A, Panayiotides J, Karakitsos P: Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 women. BMC Cancer 2010, 10: 53. 10.1186/1471-2407-10-53PubMedPubMedCentralCrossRef

20.

Pindborg JJ, Sirsat SM: Oral sub mucous fibrosis. Oral Surg Oral Med Oral Pathol 1966,22(6):764-79. 10.1016/0030-4220(66)90367-7PubMedCrossRef

21.

Prusty BK, Das BC: Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005,113(6):951-60. 10.1002/ijc.20668PubMedCrossRef

22.

Fleiss JL: Statistical methods for rates and proportions. 3rd edition. John Wiley and Sons, New York; 1981:212-236.

23.

Peyton CL, Schiffman M, Lörincz AT, Hunt WC, Mielzynska I, Bratti C, Eaton S, Hildesheim A, Morera LA, Rodriguez AC, Herrero R, Sherman ME, Wheeler CM: Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998,36(11):3248-54.PubMedPubMedCentral

24.

Kulmala SM, Syrjänen S, Shabalova I, Petrovichev N, Kozachenko V, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Grunberga V, Juschenko A, Tosi P, Santopietro R, Syrjänen K: Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol 2004,42(6):2470-5. 10.1128/JCM.42.6.2470-2475.2004PubMedPubMedCentralCrossRef

25.

Mehrotra R, Chaudhary AK, Pandya S, Debnath S, Singh M, Singh M: Correlation of addictive factors, human papilloma virus infection and histopathology of oral sub mucous fibrosis. J Oral Pathol Med 2010, 39: 460-64. 10.1111/j.1600-0714.2009.00849.xPubMedCrossRef

26.

Kujan O, Desai M, Sargent A, Bailey A, Turner A, Sloan P: Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa. Oral Oncol 2006,42(8):810-8. 10.1016/j.oraloncology.2005.11.024PubMedCrossRef

27.

Vidal A, Junior A, Mello R: HPV detedtion in oral carcinoma. J Bras Patol Med Lab 2004, 40: 21-26. 10.1590/S1676-24442004000100007CrossRef

Title: Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma
Authors: Ajay Kumar Chaudhary
Shruti Pandya
Ravi Mehrotra
Alok C Bharti
Mangal Singh
Mamta Singh
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/1743-422X-7-253

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma

Abstract

Background

Methods and materials

Result

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods and materials

Result

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2010

Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus

Presence of Human Herpes Virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection

Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch

Concentration of acrylamide in a polyacrylamide gel affects VP4 gene coding assignment of group A equine rotavirus strains with P[12] specificity

3'-coterminal subgenomic RNAs and putative cis-acting elements of Grapevine leafroll-associated virus 3 reveals 'unique' features of gene expression strategy in the genus Ampelovirus

A role for the histone deacetylase HDAC4 in the life-cycle of HIV-1-based vectors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page